BIEL Stock Overview
BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
BioElectronics Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.00015 |
| 52 Week High | US$0.0007 |
| 52 Week Low | US$0.0001 |
| Beta | 0 |
| 1 Month Change | -50.00% |
| 3 Month Change | -25.00% |
| 1 Year Change | -62.50% |
| 3 Year Change | -94.83% |
| 5 Year Change | -78.57% |
| Change since IPO | -99.97% |
Recent News & Updates
Recent updates
Shareholder Returns
| BIEL | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -25.0% | 1.4% | 1.2% |
| 1Y | -62.5% | -0.7% | 24.7% |
Return vs Industry: BIEL underperformed the US Medical Equipment industry which returned -0.7% over the past year.
Return vs Market: BIEL underperformed the US Market which returned 24.7% over the past year.
Price Volatility
| BIEL volatility | |
|---|---|
| BIEL Average Weekly Movement | 56.7% |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BIEL's share price has been volatile over the past 3 months.
Volatility Over Time: BIEL's weekly volatility has increased from 42% to 57% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | n/a | Kelly Whelan | www.bielcorp.com |
BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, as well as heals muscle and tendon injuries, sores, and incisions.
BioElectronics Corporation Fundamentals Summary
| BIEL fundamental statistics | |
|---|---|
| Market cap | US$3.71m |
| Earnings (TTM) | -US$289.82k |
| Revenue (TTM) | US$1.61m |
0.0x
P/S Ratio0.0x
P/E RatioIs BIEL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIEL income statement (TTM) | |
|---|---|
| Revenue | US$1.61m |
| Cost of Revenue | US$813.93k |
| Gross Profit | US$795.53k |
| Other Expenses | US$1.09m |
| Earnings | -US$289.82k |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did BIEL perform over the long term?
See historical performance and comparison